I studied Analytical Chemistry and has completed my MS in Total Quality Management from Punjab University Lahore-Pakistan. I joined Surge Laboratories Private Limited in 2004 and immediately excelled in my executive career track. I am working as General Manager Technical Operations in one of the leading pharmaceutical and cosmetic manufacturing group in Pakistan. My research interests include New Drug Delivery Systems, Nano-Technology, Quality Risk Management, Cleaning Validation, Microencapsulation of APIs, Pharmaceutical cGMP, Process Analytical Technology, Role of Mass Spectrometry in Pharmaceuticals & Hot Melt Extrusion Technology. I have presented various talks in USA, Canada, UK, Thailand and UAE on Cleaning Validation, GXP, Quality Risk Management, Role of Mass Spectrometry in Pharmaceuticals and on new Drug Delivery Systems.
Presently my role as General Manager Technical Operations is to search new techniques and processes, identification of new technologies, and advice on the introduction of new machinery or materials for the project. I am also responsible to lead and implement Quality Management System and cGMP compliance at plant. Provide clear leadership and vision, inspire and motivate staff to achieve operational excellence. Monitor and report Key Performance Indicators (KPIs) across all relevant areas of the business. Ensure product quality related matters are prioritized to drive Continuous Improvement in line with the business strategy.
Case Study
Thursday, July 18
04:00 pm - 04:30 pm
Live in Singapore
Less Details
Pharmaceutical Nanotechnology is the sensational, quickly evolving branch of medical science that deals with connecting nanoscale materials as drug delivery and/or diagnostic tools. As drug delivery tools, nano-delivery systems can be used to enhance the site-specific, targeted delivery of precise medicines. This typically results in significant reductions in side effects and concomitant improvements in efficacy. Nanotechnology signifies a platform for evolving innovative modifications and improvements to many kind of features of pharmaceutical manufacturing. Also, the rate of nanotechnology discovery is proceeding more rapidly than practical applications in the field of pharmaceutical manufacturing. Nanotechnology generally refers to structures that are up to several hundred nanometers in size. Nanomedicines and nano drug delivery systems are relatively new but rapidly developing science where materials in the nanoscale range are employed to serve as means of diagnostic tools or to deliver therapeutic agents to specific targeted sites in a controlled manner. Novel drug delivery systems have several advantages over conventional multi dose therapy. Nanoparticles can offer significant advantages over the conventional drug delivery in terms of high stability, high specificity, high drug carrying capacity, ability for controlled release, possibility to use in different route of administration and the capability to deliver both hydrophilic and hydrophobic drug molecules. A well-designed drug delivery system can overcome some of the problems of conventional therapy and enhance the therapeutic efficacy of a particular drug. The intent of the study is to highlight the potential of nanoparticle formulation and their applications in pharmaceutical manufacturing. This study will also describe the challenges and future nanotechnology strategies to overcome limitations in this field.
This presentation covers: